triamcinolone acetonide has been researched along with Iris Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arepalli, S; Manjandavida, FP; Shields, CL; Tarlan, B | 1 |
| Carlson, RD; Crozier, I; Debiec, MR; Hill, CE; Kraft, CS; Kumar, G; Lyon, GM; Martin, DF; Mehta, AK; Nussenblatt, RB; Olsen, TW; Patel, PS; Ribner, BS; Shantha, JG; Smith, JR; Ströher, U; Uyeki, TM; Varkey, JB; Yeh, S | 1 |
| Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B | 1 |
| Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I | 1 |
| Boyle, NS; Zalta, AH; Zalta, AK | 1 |
1 review(s) available for triamcinolone acetonide and Iris Diseases
| Article | Year |
|---|---|
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2004 |
4 other study(ies) available for triamcinolone acetonide and Iris Diseases
| Article | Year |
|---|---|
Optical coherence tomography characteristics of epi-iridic membrane in a child with recurrent hyphema and presumed juvenile xanthogranuloma.
Topics: Administration, Topical; Basement Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans; Hyphema; Infant; Injections, Intraocular; Iridocyclitis; Iris Diseases; Prednisolone; Recurrence; Tomography, Optical Coherence; Triamcinolone Acetonide; Xanthogranuloma, Juvenile | 2014 |
Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor.
Topics: Administration, Oral; Adult; Amides; Atropine; Drug Combinations; Ebolavirus; Eye Infections, Viral; Fluprednisolone; Glucocorticoids; Hemorrhagic Fever, Ebola; Humans; Injections, Intraocular; Iris Diseases; Male; Microscopy, Acoustic; Multimodal Imaging; Mydriatics; Ophthalmic Solutions; Panuveitis; Pigmentation Disorders; Prednisone; Pyrazines; Real-Time Polymerase Chain Reaction; RNA, Viral; Survivors; Triamcinolone Acetonide; Vitreous Body | 2016 |
[Complications of intravitreal injections--own experience].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 2011 |
Silicone oil pupillary block: an exception to combined argon-Nd:YAG laser iridotomy success in angle-closure glaucoma.
Topics: Combined Modality Therapy; Dexamethasone; Glaucoma, Angle-Closure; Glucocorticoids; Humans; Intraocular Pressure; Iridectomy; Iris Diseases; Laser Therapy; Retinal Detachment; Retrospective Studies; Silicone Oils; Tissue Plasminogen Activator; Tonometry, Ocular; Treatment Failure; Triamcinolone Acetonide; Vitrectomy | 2007 |